ENTITY

Kymera Therapeutics (KYMR US)

2
Analysis
Health CareUnited States
Kymera Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Kymera Therapeutics serves customers in the State of Massachusetts.
more
Exchange Announcement11 Dec 2025 06:17
Exchange Announcement11 Dec 2025 05:25
Exchange Announcement09 Dec 2025 05:23
Exchange Announcement08 Dec 2025 21:45
Exchange Announcement08 Dec 2025 20:17
x